cisatracurium has been researched along with Innate Inflammatory Response in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batt, J; Cappello, P; Delsedime, L; Fanelli, V; Ghazarian, M; Morita, Y; Ranieri, VM; Slutsky, AS; Sugumar, B; Zhang, H | 1 |
1 other study(ies) available for cisatracurium and Innate Inflammatory Response
| Article | Year |
|---|---|
Neuromuscular Blocking Agent Cisatracurium Attenuates Lung Injury by Inhibition of Nicotinic Acetylcholine Receptor-α1.
Topics: Analysis of Variance; Animals; Atracurium; Disease Models, Animal; Inflammation; Lung Injury; Male; Mice; Mice, Inbred C57BL; Neuromuscular Blocking Agents; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic | 2016 |